Beranda › Sklerosis Multipel › Illinois
Uji klinis Sklerosis Multipel di Illinois
19 studi untuk Sklerosis Multipel mencari peserta di lokasi di Illinois.
Kota di Illinois
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Chicago
- TG Therapeutics Investigational Trial Site, Chicago
- TG Therapeutics Investigational Trial Site, Evanston
- dan 1 lainnya
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Consultants in Neurology- Site Number : 8400020, Northbrook
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of Chicago Medical Center, Chicago
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06408259Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
- Shirley Ryan AbilityLab, Chicago
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07132775A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07225504Ocrevus Zunovo for MS: Mixed Methods
- Northwestern Memorial Hospital, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Jul 2026 · NCT07710105Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
- University of Illinois at Chicago, Chicago
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT06410261Functional Balance Intervention in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06341023Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Menerima peserta
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT05051618Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
- Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07167680Nomad P-KAFO Study
- Shirley Ryan AbilityLab, Chicago
Menerima peserta
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT05644522Intermittent Hypoxia in Persons With Multiple Sclerosis
- Shirley Ryan AbilityLab, Chicago
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT06276634People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Northwestern Memorial Hospital, Chicago
Menerima pesertaStudi observasional
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07207148Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
- Northwestern Memorial Hospital, Chicago
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT07225361Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
- Shirley Ryan AbilityLab, Chicago
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT06390930Home Based Functional Balance Intervention for Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Menerima peserta
Usia 40 hingga 90 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT07355387An Individualized-health eLibrary App for People With Multiple Sclerosis
- University of Illinois Urbana-Champaign, Champaign
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2025 · NCT05124600Remote Evaluation of MIND Diet
- University of Illinois Urbana-Champaign, Urbana
Menerima peserta
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 27 Jun 2024 · NCT06450977Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.